|
1
|
Roupret M, Babjuk M, Comperat E, Zigeuner
R, Sylvester RJ, Burger M, Cowan NC, Böhle A, Van Rhijn BW,
Kaasinen E, et al: European association of urology guidelines on
upper urinary tract urothelial cell carcinoma: 2015 update. Eur
Urol. 68:868–879. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Liu JY, Dai YB, Zhou FJ, Long Z, Li YH,
Xie D, Liu B, Tang J, Tan J, Yao K and He LY: Laparoscopic versus
open nephroureterectomy to treat localized and/or locally advanced
upper tract urothelial carcinoma: Oncological outcomes from a
multicenter study. BMC Surg. 17(17)2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Templeton AJ, Ace O, McNamara MG,
Al-Mubarak M, Vera-Badillo FE, Hermanns T, Seruga B, Ocaña A,
Tannock IF and Amir E: Prognostic role of platelet to lymphocyte
ratio in solid tumors: A systematic review and meta-analysis.
Cancer Epidemiol Biomarkers Prev. 23:1204–1212. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Teng JJ, Zhang J, Zhang TY, Zhang S and Li
BS: Prognostic value of peripheral blood lymphocyte-to-monocyte
ratio in patients with solid tumors: A meta-analysis. Onco Targets
Ther. 9:37–47. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Koh CH, Bhoo-Pathy N, Ng KL, Jabir RS, Tan
GH, See MH, Jamaris S and Taib NA: Utility of pre-treatment
neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as
prognostic factors in breast cancer. Br J Cancer. 113:150–158.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gunduz S, Mutlu H, Tural D, Yildiz O,
Uysal M, Coskun HS and Bozcuk H: Platelet to lymphocyte ratio as a
new prognostic for patients with metastatic renal cell cancer. Asia
Pac J Clin Oncol. 11:288–292. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Allin KH and Nordestgaard BG: Elevated
C-reactive protein in the diagnosis, prognosis, and cause of
cancer. Crit Rev Clin Lab Sci. 48:155–170. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kang M, Jeong CW, Kwak C, Kim HH and Ku
JH: Preoperative neutrophil-lymphocyte ratio can significantly
predict mortality outcomes in patients with non-muscle invasive
bladder cancer undergoing transurethral resection of bladder tumor.
Oncotarget. 8:12891–12901. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yuksel OH, Akan S, Uukmez A, Yildirim C,
Sahin A and Verit A: Preoperative Glasgow prognostic score as a
predictor of primary bladder cancer recurrence. Mol Clin Oncol.
5:201–206. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yamashita H, Kitayama J, Kanno N, Yatomi Y
and Nagawa H: Hyperfibrinogenemia is associated with lymphatic as
well as hematogenous metastasis and worse clinical outcome in T2
gastric cancer. BMC Cancer. 6(147)2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yamashita H, Kitayama J and Nagawa H:
Hyperfibrinogenemia is a useful predictor for lymphatic metastasis
in human gastric cancer. Jpn J Clin Oncol. 35:595–600.
2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Palumbo JS, Potter JM, Kaplan LS, Talmage
K, Jackson DG and Degen JL: Spontaneous hematogenous and lymphatic
metastasis, but not primary tumor growth or angiogenesis, is
diminished in fibrinogen-deficient mice. Cancer Res. 62:6966–6972.
2002.PubMed/NCBI
|
|
14
|
Fan S, Guan Y, Zhao G and An G:
Association between plasma fibrinogen and survival in patients with
small-cell lung carcinoma. Thorac Cancer. 9:146–151.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pichler M, Hutterer GC, Stojakovic T,
Mannweiler S, Pummer K and Zigeuner R: High plasma fibrinogen level
represents an independent negative prognostic factor regarding
cancer-specific, metastasis-free, as well as overall survival in a
European cohort of non-metastatic renal cell carcinoma patients. Br
J Cancer. 109:1123–1129. 2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Erdem S, Amasyali AS, Aytac O, Onem K,
Issever H and Sanli O: Increased preoperative levels of plasma
fibrinogen and d dimer in patients with renal cell carcinoma is
associated with poor survival and adverse tumor characteristics.
Urol Oncol. 32:1031–1040. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sobin LH, Gospodarowicz MK and Wittekind
Ch (eds): TNM Classification of Malignant Tumours, 7th Edition.
Wiley-Blackwell, Hoboken, NJ, 2009.
|
|
18
|
The International Agency for Research on
Cancer (IARC): Pathology and Genetics of Tumours of the Urinary
System and Male Genital Organs (IARC WHO Classification of Tumours)
1st Edition. Eble J, Epstein J, Sesterhenn I and Sauter G (eds).
World Health Organization, Geneva, 2004.
|
|
19
|
Qu J, Qu X, Li Z, Zhang Jd, Liu J, Teng
Ye, Jin B, Zhao Mf, Yu P, Shi J, et al: Prognostic model based on
systemic inflammatory response and clinicopathological factors to
predict outcome of patients with node-negative gastric cancer. PLoS
One. 10(0128540)2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tanaka N, Kikuchi E, Matsumoto K, Hayakawa
N, Ide H, Miyajima A, Nakamura S and Oya M: Prognostic value of
plasma fibrinogen levels in patients with localized upper tract
urothelial carcinoma. BJU Int. 111:857–864. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kasuga J, Kawahara T, Takamoto D, Fukui S,
Tokita T, Tadenuma T, Narahara M, Fusayasu S, Terao H, Izumi K, et
al: Increased neutrophil-to-lymphocyte ratio is associated with
disease-specific mortality in patients with penile cancer. BMC
Cancer. 16(396)2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Uemura K, Kawahara T, Yamashita D, Jikuya
R, Abe K, Tatenuma T, Yokomizo Y, Izumi K, Teranishi JI, Makiyama
K, et al: Neutrophil-to-lymphocyte ratio predicts prognosis in
castration-resistant prostate cancer patients who received
cabazitaxel chemotherapy. Biomed Res Int.
2017(7538647)2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lee JH, Ryu KW, Kim S and Bae JM:
Preoperative plasma fibrinogen levels in gastric cancer patients
correlate with extent of tumor. Hepatogastroenterology.
51:1860–1863. 2004.PubMed/NCBI
|
|
24
|
HKitayama JY, Hatano K, Tsuno N, Osada T,
Watanabe T, Tsuruo T, Muto T and Nagawa H: Clustered cancer cells
show a distinct adhesion behavior from single cell form under
physiological shear conditions. J Exp Clin Cancer Res. 20:407–412.
2001.PubMed/NCBI
|
|
25
|
Çalışkan S and Sungur M: Fibrinogen and
D-dimer levels in prostate cancer: Preliminary results. Prostate
Int. 5:110–112. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Palumbo JS, Kombrinck KW, Drew AF, Grimes
TS, Kiser JH, Degen JL and Bugge TH: Fibrinogen is an important
determinant of the metastatic potential of circulating tumor cells.
Blood. 96:3302–3309. 2000.PubMed/NCBI
|
|
27
|
Kuroda K, Asakuma J, Horiguchi A,
Kawaguchi M, Shinchi M, Masunaga A, Tasaki S, Sato A and Ito K:
Chronic kidney disease and positive surgical margins as
prognosticators for upper urinary tract urothelial carcinoma
patients undergoing radical nephroureterectomy. Mol Clin Oncol.
10:547–554. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bagoly Z: Cancer and thrombosis: A fresh
look at an old story. Thromb Res. 136:1–2. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Thurner EM, Krenn-Pilko S, Langsenlehner
U, Stojakovic T, Pichler M, Gerger A, Kapp KS and Langsenlehner T:
The association of an elevated plasma fibrinogen level with
cancer-specific and overall survival in prostate cancer patients.
World J Urol. 33:1467–1473. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sakano S, Inamoto T, Inoue R, Matsumoto H,
Nagao K, Yamamoto Y, Azuma H and Matsuyama H: Positive voided urine
cytology predicts worse pathological findings of nephroureterectomy
specimens in patients with upper tract urothelial carcinoma: Does
selective ureteral cytology have an additional efficacy? Jpn J Clin
Oncol. 45:968–972. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ito Y, Kikuchi E, Tanaka N, Miyajima A,
Mikami S, Jinzaki M and Oya M: Preoperative hydronephrosis grade
independently predicts worse pathological outcomes in patients
undergoing nephroureterectomy for upper tract urothelial carcinoma.
J Urol. 185:1621–1626. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Tanaka N, Kikuchi E, Kanao K, Matsumoto K,
Shirotake S, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, et
al: The predictive value of positive urine cytology for outcomes
following radical nephroureterectomy in patients with primary upper
tract urothelial carcinoma: A multi-institutional study. Urol
Oncol. 32:e19–e26. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kohada Y, Hayashi T, Goto K, Kobatake K,
Abdi H, Honda Y, Sentani K, Inoue S, Teishima J, Awai K, et al:
Preoperative risk classification using neutrophil-lymphocyte ratio
and hydronephrosis for upper tract urothelial carcinoma. Jpn J Clin
Oncol. 48:841–850. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Chung PH, Krabbe LM, Darwish OM, Westerman
ME, Bagrodia A, Gayed BA, Haddad AQ, Kapur P, Sagalowsky AI, Lotan
Y and Margulis V: Degree of hydronephrosis predicts adverse
pathological features and worse oncologic outcomes in patients with
high-grade urothelial carcinoma of the upper urinary tract. Urol
Oncol Semin Orig Investig. 32:981–988. 2014.PubMed/NCBI View Article : Google Scholar
|
